Generic medicine

Latanoprost 0.005% w/v Eye drops

Reviewed educational reference: what Latanoprost is used for, how it works, its side effects and safety advice, plus the Indian brands that contain it.

Reviewed by Sohan Lal Kushwaha
Molecule
Latanoprost
Strength
0.005% w/v
Dosage form
Eye drops
Drug class
Prostaglandin F2-alpha analogue

Related products

No reviewed products are currently published for this generic.

Latanoprost 0.005% w/v Eye drops contains Latanoprost, a selective prostanoid FP receptor agonist that reduces intraocular pressure by increasing the outflow of aqueous humour. It is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Latanoprost is a prodrug that is hydrolysed in the cornea to its biologically active acid form, which then exerts its effect on the uveoscleral pathway.

At a glance

Quick look

Latanoprost 0.005% w/v Eye drops is a prostaglandin analogue eye drop.

How it works

It lowers eye pressure by increasing the drainage of fluid from the eye.

Who it is for

It is used to treat open-angle glaucoma and ocular hypertension.

Uses it for
Open-angle glaucomaOcular hypertensionHigh eye pressureGlaucoma managementIntraocular pressure controlAdjunctive therapy

Uses of Latanoprost

  • Reduction of elevated intraocular pressure in open-angle glaucoma.
  • Management of ocular hypertension.
  • Treatment of patients who are intolerant to other pressure-lowering medications.
  • Adjunctive therapy in patients not responding to beta-blockers.
  • Long-term maintenance of target intraocular pressure.
  • Prevention of optic nerve damage associated with high eye pressure.

Benefits of Latanoprost

Effective Pressure Reduction
The primary benefit of Latanoprost 0.005% w/v Eye drops is its potent ability to lower intraocular pressure, which is the most significant risk factor for the progression of glaucoma. By facilitating the drainage of fluid from the eye, it helps preserve the visual field and prevents further damage to the optic nerve.

Convenient Once-Daily Dosing
Unlike many other antiglaucoma medications that require multiple applications throughout the day, Latanoprost 0.005% w/v Eye drops is typically administered only once in the evening. This simplifies the treatment regimen, improves patient adherence, and reduces the likelihood of missed doses, which is critical for maintaining stable eye pressure.

Side effects of Latanoprost

The most common side effect of Latanoprost 0.005% w/v Eye drops is a gradual change in eye colour, specifically an increase in the amount of brown pigment in the iris. This change is usually permanent and more noticeable in patients with mixed-colour irises. Other frequent effects include eyelash changes, such as increased length, thickness, and pigmentation, and mild to moderate eye irritation or redness. Some patients may experience blurred vision, a sensation of a foreign body in the eye, or dry eyes. Less common but serious reactions include macular oedema, iritis, or uveitis. If you notice persistent eye pain, severe redness, or sudden changes in your vision, seek medical advice immediately. While many side effects are local to the eye, systemic absorption can rarely cause respiratory symptoms or muscle pain.

Side effectHow commonHow severeWhat to do
Increased iris pigmentationCommonMildMonitor iris colour regularly during routine check-ups.
Ocular irritationCommonMildEnsure proper application technique to avoid direct contact with the eyelid skin.
Eyelash changesCommonMildNone required as this is a cosmetic change.

How to manage side effects

Increased iris pigmentation

  • No specific treatment is required as this is a known effect.
  • Continue monitoring for any signs of inflammation.

Ocular irritation

  • Use lubricating eye drops if irritation persists.
  • Consult your doctor if redness or pain becomes severe.

Eyelash changes

  • No intervention is necessary.
  • Inform the patient that this effect is reversible upon discontinuation.

How to use Latanoprost

  • Wash your hands thoroughly before handling the eye drop bottle.
  • Tilt your head back and pull down your lower eyelid to create a small pocket.
  • Hold the dropper above the eye and squeeze one drop into the pocket.
  • Close your eye gently and press your finger against the inner corner of the eye for one minute to prevent systemic absorption.
  • If you wear contact lenses, remove them before application and wait at least 15 minutes before reinserting them.
  • Do not let the tip of the dropper touch your eye or any other surface to prevent contamination.

Special population advice

Kidney impairment

  • No specific dose adjustment is required.
  • Monitor intraocular pressure regularly.

Liver impairment

  • No specific dose adjustment is required.
  • Use with caution in severe hepatic disease.

Children

  • Use only if the benefit outweighs the risk.
  • Monitor for potential side effects like hypertrichosis.

Elderly

  • No dose adjustment required.
  • Monitor for potential systemic effects if multiple medications are used.

How Latanoprost works

Latanoprost acts as a selective agonist for the prostaglandin F2-alpha receptor. By binding to these receptors in the ciliary muscle, it increases the uveoscleral outflow of aqueous humour from the eye. This reduction in fluid volume effectively lowers intraocular pressure, thereby reducing the mechanical stress on the optic nerve head.

What if you miss or exceed a dose?

If you miss a dose

If you miss a dose of Latanoprost 0.005% w/v Eye drops, skip the missed dose and continue with your next scheduled dose at the usual time. Do not apply a double dose to make up for the one you missed, as this will not provide additional benefit and may increase the risk of ocular irritation.

In case of overdose

Accidental ingestion of Latanoprost 0.005% w/v Eye drops is unlikely to cause serious systemic toxicity due to the low concentration of the active ingredient. However, if a large amount is swallowed, you may experience nausea, abdominal pain, dizziness, or flushing. In case of ocular overdose, flush the eye with plenty of water. Contact a poison control centre or your doctor if you are concerned about ingestion.

AntidoteNo specific antidote

Treatment is symptomatic and supportive.

Ocular Overdose
Flush the eye thoroughly with water or saline solution.
Systemic Ingestion
Monitor for signs of systemic toxicity such as nausea or abdominal pain.
Supportive Care
Provide symptomatic treatment if systemic symptoms occur.
Medical Consultation
Contact a poison control centre if a significant quantity is ingested.

Safety and precautions

When to avoid Latanoprost

Do not take if you
  • Hypersensitivity

    Do not use if allergic to latanoprost or any component of the formulation.

  • Active ocular inflammation

    Use with extreme caution in patients with active intraocular inflammation.

Use with caution
  • Aphakia

    Use with caution in patients with aphakia or pseudophakia with a torn posterior lens capsule.

  • Macular oedema

    Monitor closely in patients with a history of macular oedema.

  • Asthma

    Use with caution in patients with a history of severe asthma.

  • Herpetic keratitis

    Avoid use in patients with a history of recurrent herpetic keratitis.

Safety at a glance

AlcoholSafe

Alcohol does not directly interact with the ocular application of this drug.

PregnancyConsult your doctor

Use only if the potential benefit justifies the potential risk to the foetus.

BreastfeedingConsult your doctor

Consult your doctor as it is unknown if the drug passes into breast milk.

DrivingUse with caution

May cause temporary blurred vision; do not drive until vision clears.

KidneySafe

No dose adjustment is typically required for patients with renal impairment.

LiverSafe

No dose adjustment is typically required for patients with hepatic impairment.

AllergyUnsafe

Do not use if you have a known hypersensitivity to latanoprost or any excipients.

ChildrenUse with caution

Safety and efficacy in paediatric patients have not been fully established.

ElderlySafe

No specific dose adjustment is required for the elderly population.

Interactions

With other medicines

Thiomersal-containing eye drops

Moderate

Changes how the medicine is processed

What can happen: Precipitation of the drug in the eye.

What to do: Avoid using these products simultaneously; space applications by at least 5 minutes.

Other prostaglandin analogues

Moderate

Changes the medicine’s effect

What can happen: Paradoxical increase in intraocular pressure.

What to do: Do not use more than one prostaglandin analogue concurrently.

Systemic beta-blockers

Minor

Changes the medicine’s effect

What can happen: Additive pressure-lowering effect.

What to do: Monitor intraocular pressure to ensure it does not drop too low.

With food and drink

  • None knownMinor

    There are no known food interactions with topical ophthalmic latanoprost.

  • Grapefruit juiceMinor

    Does not significantly alter systemic levels of topically applied latanoprost, but general dietary caution applies.

If you have another condition

  • Uveitis

    May exacerbate inflammation; use only under strict medical supervision.

  • Macular Oedema

    Risk of cystoid macular oedema in predisposed patients.

Effect on laboratory tests

  • Intraocular pressure measurement

    <b>Lowered readings</b>

    The drug is intended to lower pressure, so readings will be lower than baseline.

Quick tips

  • Apply Latanoprost 0.005% w/v Eye drops in the evening for optimal efficacy.
  • Wait at least 5 minutes between applying Latanoprost 0.005% w/v Eye drops and any other eye drops.
  • Inform your doctor if you are planning to undergo cataract surgery.
  • Monitor your eye colour periodically as iris pigmentation may change over time.
  • Store the unopened bottle in a refrigerator between 2°C and 8°C.
  • Once opened, the bottle can be stored at room temperature (below 25°C) for up to 4 weeks.

Counselling points

  • Iris PigmentationImportant

    Be aware that your eye colour may darken over time due to increased melanin in the iris.

  • HygieneImportant

    Do not touch the dropper tip to your eye or any surface to prevent bacterial contamination.

  • Contact LensesImportant

    Remove contact lenses before use and wait 15 minutes before reinsertion.

  • Eyelash ChangesGood to know

    You may notice your eyelashes becoming longer, thicker, and darker; this is a known effect of the medicine.

Monitoring during treatment

Before starting

  • Intraocular pressure measurement
  • Slit-lamp examination of the iris
  • Visual field assessment

During treatment

  • every 3 months: Monitor intraocular pressure and check for iris pigmentation changes.

What is being watched

  • Intraocular pressure
  • Iris colour
  • Eyelash growth
  • Corneal integrity

Pharmacokinetics

Absorption
Rapidly absorbed through the cornea.
Bioavailability
High, as it is a prodrug.
Protein binding
Approximately 87% in plasma.
Volume of distribution
0.16 L/kg.
Half-life
Approximately 17 minutes.
Metabolism
Hydrolysed by esterases in the cornea and plasma to the active acid form.
Excretion
Primarily via urine after hepatic metabolism.
Onset / duration
Onset within 3-4 hours; duration of action 24 hours.

Fact box

Chemical class
Prostaglandin analogue
Habit forming
No
Therapeutic class
Antiglaucoma agent
Action class
Prostanoid FP receptor agonist
Storage
Store unopened bottles in a refrigerator (2-8°C). Once opened, store at room temperature (below 25°C) and discard after 4 weeks.
ATC code
S01EE01
Pregnancy category
C

More information

Clinical Rationale for Latanoprost

Clinicians frequently select Latanoprost as a first-line treatment for open-angle glaucoma due to its superior efficacy in lowering intraocular pressure compared to many other classes of antiglaucoma drugs. Its mechanism of action, which involves increasing uveoscleral outflow, provides a unique physiological advantage. Unlike beta-blockers, which can have systemic cardiovascular and pulmonary side effects, Latanoprost is applied topically and has minimal systemic absorption, making it a safer choice for patients with comorbidities like asthma or bradycardia. The once-daily dosing regimen significantly enhances patient compliance, which is the cornerstone of successful long-term glaucoma management.

Comparison with Alternatives

When compared to beta-blockers such as timolol, Latanoprost often demonstrates a more consistent reduction in intraocular pressure over a 24-hour period. While beta-blockers work by reducing the production of aqueous humour, Latanoprost enhances its drainage. Some patients may require combination therapy if monotherapy is insufficient. Carbonic anhydrase inhibitors and alpha-agonists are other alternatives, but they are often associated with a higher incidence of local allergic reactions or systemic side effects. Latanoprost remains the gold standard for many practitioners due to its balance of high efficacy and a relatively favourable safety profile in the eye.

Lifestyle and Treatment Expectations

Patients starting Latanoprost 0.005% w/v Eye drops should be prepared for a long-term commitment to therapy. Glaucoma is a chronic condition, and the medication must be used consistently to prevent irreversible optic nerve damage. It is common for patients to worry about the cosmetic changes, such as iris darkening or eyelash growth. While these are clinically benign, they can be distressing, and it is important to discuss these expectations during the initial consultation. Lifestyle adjustments are minimal, but patients should maintain regular follow-up appointments to ensure that the target intraocular pressure is being achieved and that there is no progression of visual field loss.

Common Misconceptions

A frequent misconception is that Latanoprost 0.005% w/v Eye drops will cure glaucoma or reverse existing vision loss. It is vital to clarify that the medication only slows the progression of the disease by managing pressure. Another myth is that the eye colour change is a sign of an allergic reaction; in reality, it is a pharmacological effect of the drug on melanocytes. Patients also often believe that if they feel no symptoms, they can stop the medication. This is dangerous, as glaucoma is often asymptomatic until significant vision loss has already occurred. Adherence to the prescribed regimen is essential regardless of how the eye feels on a day-to-day basis.

References

  1. Medicines and Healthcare products Regulatory Agency. Latanoprost 50 micrograms/ml eye drops, solution, Summary of Product Characteristics.View sourceAccessed
  2. Medical Products Agency. Latanoprost Actavis eye drops, solution, Summary of Product Characteristics.View sourceAccessed
  3. National Agency for Food and Drug Administration and Control. Porstan Eye Drops, Summary of Product Characteristics.View sourceAccessed
  4. U.S. Food and Drug Administration. Latanoprost Ophthalmic Solution label.View sourceAccessed
  5. Tripathi KD. Essentials of Medical Pharmacology. 8th ed. Jaypee Brothers Medical Publishers, 2019.Accessed

Frequently asked questions about Latanoprost

Can I use Latanoprost 0.005% w/v Eye drops if I wear contact lenses?

Yes, but you must remove your contact lenses before applying the drops and wait at least 15 minutes before putting them back in.

Will my eye colour change permanently?

Yes, the increase in brown pigment in the iris is usually permanent and may continue to increase as long as you use the medication.

How long does it take for Latanoprost 0.005% w/v Eye drops to work?

The reduction in intraocular pressure usually begins within 3 to 4 hours after the first dose, with maximum effect reached within 8 to 12 hours.

Can I use Latanoprost 0.005% w/v Eye drops with other eye drops?

Yes, but wait at least 5 minutes between applying different types of eye drops to ensure proper absorption.

What should I do if I get the drops in my mouth?

Rinse your mouth with water. The systemic absorption from a single drop is minimal, but contact your doctor if you feel unwell.

Latest